Organovo Holdings, Inc. (ONVO)
ONVO moved a median of -0.95% 30 minutes after news, and -1.96% by the close. How ONVO actually reacts to news — the realized, point-in-time move the market made, measured across 87 labeled events over the last three years with zero look-ahead.
ONVO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 35% | 82 |
| 30-min | -0.95% | 37% | 83 |
| 60-min | -1.49% | 41% | 83 |
| to close | -1.96% | 35% | 83 |
| Middle 50% of ONVO reactions | -4.47% to +0.94% |
|---|---|
| Median reaction (30-min) | -0.95% |
| Measured reactions | 87 |
Half of all Organovo Holdings, Inc. news events land between -4.47% and +0.94% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ONVO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ONVO's baseline. Nothing else.
Recent ONVO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-K VivoSim Labs, INC. For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | — | — | |
| Form 8-K VivoSim Labs, INC. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K VivoSim Labs, INC. For: Apr 23 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Apr 23 | SEC filing · Form 8-K | SEC EDGAR | -2.31% | -5.56% | |
| VivoSim to Carry Forward Organovo 3D Bioprinting | Press release | GlobeNewswire | -2.31% | -5.56% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Apr 02 | SEC filing · Form 8-K | SEC EDGAR | +1.38% | -2.73% | |
| Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements | Press release | GlobeNewswire | +1.38% | -2.73% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Mar 27 | SEC filing · Form 8-K | SEC EDGAR | -1.02% | -11.24% | |
| Organovo Provides Business Update | Press release | GlobeNewswire | -1.02% | -11.24% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Mar 21 | SEC filing · Form 8-K | SEC EDGAR | -3.40% | -12.18% | |
| Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company | Press release | GlobeNewswire | +2.31% | +0.00% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Mar 20 | SEC filing · Form 8-K | SEC EDGAR | +4.43% | -15.13% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Mar 19 | SEC filing · Form 8-K | SEC EDGAR | +0.03% | -16.14% | |
| Organovo Announces Reverse Stock Split | Press release | GlobeNewswire | +0.03% | -16.14% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Mar 06 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -7.46% | |
| Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises | Press release | GlobeNewswire | +0.00% | -7.46% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Feb 19 | SEC filing · Form 8-K | SEC EDGAR | -6.45% | +2.42% | |
| Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company | Press release | GlobeNewswire | -6.45% | +2.42% | |
| Form 10-Q ORGANOVO HOLDINGS, INC. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -3.33% | |
| Form NT 10-Q ORGANOVO HOLDINGS, INC. For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.93% | -1.80% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Jan 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.26% | |
| Organovo Announces Appointment of Norman Staskey as Chief Financial Officer | Press release | GlobeNewswire | -4.25% | +3.62% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Dec 23 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +27.75% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Nov 20 | SEC filing · Form 8-K | SEC EDGAR | -2.78% | +11.11% | |
| Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting | Press release | GlobeNewswire | +7.35% | +2.94% | |
| Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases | Press release | GlobeNewswire | -0.39% | -0.39% | |
| Form 10-Q ORGANOVO HOLDINGS, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.03% | -0.65% | |
| Form S-1 ORGANOVO HOLDINGS, INC. | SEC filing · Form S-1 | SEC EDGAR | -5.58% | -2.73% | |
| Form ARS ORGANOVO HOLDINGS, INC. For: Mar 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | -1.96% | |
| Form DEF 14A ORGANOVO HOLDINGS, INC. For: Oct 04 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -1.96% | |
| Form DEFA14A ORGANOVO HOLDINGS, INC. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -1.96% | |
| Form PRE 14A ORGANOVO HOLDINGS, INC. For: Sep 18 | SEC filing · Form PRE | SEC EDGAR | +0.00% | -4.34% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +4.53% | +8.18% | |
| Form 10-Q ORGANOVO HOLDINGS, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.59% | -0.04% | |
| Form 10-K/A ORGANOVO HOLDINGS, INC. For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | -1.67% | -5.33% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Jul 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.76% | |
| Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis | Press release | GlobeNewswire | -10.91% | -3.13% | |
| Form 10-K ORGANOVO HOLDINGS, INC. For: Mar 31 | SEC filing · Form 10-K | SEC EDGAR | +7.00% | +4.00% | |
| Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease | Press release | GlobeNewswire | -0.36% | -4.63% | |
| Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024) | Press release | GlobeNewswire | +1.56% | +6.45% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: May 08 | SEC filing · Form 8-K | SEC EDGAR | -2.08% | +3.13% | |
| Form EFFECT ORGANOVO HOLDINGS, INC. | SEC filing · Form EFFECT | SEC EDGAR | -1.14% | +12.06% | |
| Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering | Press release | GlobeNewswire | -1.14% | +12.06% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: May 01 | SEC filing · Form 8-K | SEC EDGAR | +0.01% | -4.99% | |
| Form S-1/A ORGANOVO HOLDINGS, INC. | SEC filing · Form S-1 | SEC EDGAR | +0.01% | -4.99% | |
| Form 8-K ORGANOVO HOLDINGS, INC. For: Apr 19 | SEC filing · Form 8-K | SEC EDGAR | +1.01% | +1.01% | |
| Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo | Press release | GlobeNewswire | -11.28% | -17.68% | |
| Form S-1 ORGANOVO HOLDINGS, INC. | SEC filing · Form S-1 | SEC EDGAR | -11.28% | -17.68% | |
| Form EFFECT ORGANOVO HOLDINGS, INC. | SEC filing · Form EFFECT | SEC EDGAR | -3.85% | -13.46% | |
| Form 10-Q ORGANOVO HOLDINGS, INC. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | -3.85% | -13.46% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ONVO section they belong to.
Where else ONVO is measured.
ONVO earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AMBU A S UNSP/ADR (AMBBY) | 87 | 0.00% | 13% |
| INTERPACE BIOSCIENCES INC (IDXG) | 87 | 0.00% | 48% |
| Flurotech Ltd (TEST_CDNX) | 87 | 0.00% | 41% |
| Agile Therapeutics, Inc. (AGRX) | 86 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Organovo Holdings, Inc.'s median reaction calculated?
Every labeled ONVO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 87 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 37% of ONVO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ONVO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.